VYNE Therapeutics (VYNE)
(Delayed Data from NSDQ)
$2.67 USD
+0.02 (0.75%)
Updated May 10, 2024 03:59 PM ET
After-Market: $2.66 -0.01 (-0.37%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.25 | 0.00% |
Earnings Summary
For their last quarter, VYNE Therapeutics (VYNE) reported earnings of -$0.15 per share, beating the Zacks Consensus Estimate of $-0.24 per share. This reflects a positive earnings surprise of 37.50%. Look out for VYNE's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.25 per share, reflecting a year-over-year increase of 91.88%.
Earnings History
Price & Consensus
Zacks News for VYNE
Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates
VYNE: What are Zacks experts saying now?
Zacks Private Portfolio Services